Genalyte Secures $44,000,000 Series C Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9628c92d-ac01-4f90-a620-74521dffc991 - Date
8/19/2015 - Company Name
Genalyte - Mailing Address
10520 Wateridge Circle San Diego, CA 92121 USA - Company Description
Over the past three years the team’s mission has been to develop instrument systems, hardware, software and consumables, making multiplex protein and nucleic acid testing from a single sample the standard in the Research, Life Science and Clinical Diagnostic market. - Website
http://www.genalyte.com - Transaction Type
Venture Equity - Transaction Amount
$44,000,000 - Transaction Round
Series C - Proceeds Purposes
The company intends to utilize the funding to refine the existing Maverick platform for the physician office setting, and to perform the clinical studies required to prove the accuracy of the device and suitability for use in a near-patient setting. - M&A Terms
- Venture Investor
Khosla Ventures - Venture Investor
Redmile Group - Venture Investor
Claremont Creek Ventures - Venture Investor
BioMed Ventures
